{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:13:52Z","timestamp":1791994432279,"version":"4.4.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.eplepsyres.2017.10.003","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T03:32:35Z","timestamp":1507779155000},"page":"5-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Effect of carbamazepine and oxcarbazepine on serum neuron-specific enolase in focal seizures: A randomized controlled trial"],"prefix":"10.1016","volume":"138","author":[{"given":"Rituparna","family":"Maiti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswa Ranjan","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soham","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debadatta","family":"Mohapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sansita","family":"Parida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2017.10.003_bib0005","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","article-title":"Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005\u20132009","volume":"51","author":"Berg","year":"2010","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.eplepsyres.2017.10.003_bib0010","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/10705510802339072","article-title":"What improves with increased missing data imputations?","volume":"15","author":"Bodner","year":"2008","journal-title":"Struct. Eq. Model. A Multi. J."},{"key":"10.1016\/j.eplepsyres.2017.10.003_bib0015","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s004150050383","article-title":"Serum levels of neuron-specific enolase and s-100 protein after single tonic-clonic seizures","volume":"246","author":"Buttner","year":"1999","journal-title":"J. Neurol."},{"key":"10.1016\/j.eplepsyres.2017.10.003_bib0020","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s11064-008-9817-3","article-title":"Chronic administration of mood stabilizers upregulates BDNF and bcl-2 expression levels in rat frontal cortex","volume":"34","author":"Chang","year":"2009","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.eplepsyres.2017.10.003_bib0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2377-12-15","article-title":"Clinical significance of serological biomarkers and neuropsychological performances in patients with temporal lobe epilepsy","volume":"12","author":"Chang","year":"2012","journal-title":"BMC Neurol."},{"key":"10.1016\/j.eplepsyres.2017.10.003_bib0030","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1212\/WNL.50.5.1388","article-title":"Status epilepticus increases CSF levels of neuron-specific enolase and alters the blood-brain barrier","volume":"50","author":"Correale","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2017.10.003_bib0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1528-1157.2001.19400.x","article-title":"Quantitative assessment of seizure severity for clinical trials: a review of approaches to seizure components","volume":"42","author":"Cramer","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2017.10.003_bib0040","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1528-1157.1998.tb01278.x","article-title":"Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory","volume":"39","author":"Cramer","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2017.10.003_bib0045","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1212\/WNL.45.6.1134","article-title":"Serum neuron-specific enolase in human status epilepticus","volume":"45","author":"DeGiorgio","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2017.10.003_bib0050","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/jnnp.54.10.873","article-title":"The chalfont seizure severity scale","volume":"54","author":"Duncan","year":"1991","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.eplepsyres.2017.10.003_bib0055","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.55.2.250","article-title":"Alterations in bcl-2 and caspase gene family protein expression in human temporal lobe epilepsy","volume":"55","author":"Henshall","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2017.10.003_bib0060","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1212\/WNL.59.9_suppl_5.S3","article-title":"Seizure-induced neuronal injury: animal data","volume":"59","author":"Holmes","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2017.10.003_bib0065","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0006-8993(82)90455-3","article-title":"Distribution of nervous system-specific forms of enolase in peripheral tissues","volume":"237","author":"Kato","year":"1982","journal-title":"Brain Res."},{"key":"10.1016\/j.eplepsyres.2017.10.003_bib0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1471-4159.2002.00939.x","article-title":"BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents","volume":"82","author":"Mai","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.eplepsyres.2017.10.003_bib0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-510X(00)00478-0","article-title":"Normal CSF neuron-specific enolase and S-100 protein levels in patients with recent non-complicated tonic-clonic seizures","volume":"183","author":"Palmio","year":"2001","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.eplepsyres.2017.10.003_bib0080","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.eplepsyres.2008.05.006","article-title":"Elevated serum neuron-specific enolase in patients with temporal lobe epilepsy: a video-EEG study","volume":"81","author":"Palmio","year":"2008","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2017.10.003_bib0085","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1528-1157.1996.tb00002.x","article-title":"Neuron-specific enolase is increased after single seizures during inpatient video\/EEG monitoring","volume":"37","author":"Rabinowicz","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2017.10.003_bib0090","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1136\/jnnp.46.11.1031","article-title":"Enolase isoenzymes in the cerebrospinal fluid of patients with diseases of the nervous system","volume":"46","author":"Royds","year":"1983","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.eplepsyres.2017.10.003_bib0095","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.eplepsyres.2004.07.001","article-title":"Mechanisms of epilepsy progression: current theories and perspectives from neuroplasticity in adulthood and development","volume":"60","author":"Sutula","year":"2004","journal-title":"Epilepsy Res."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121117303327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121117303327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:36:48Z","timestamp":1760276208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121117303327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":19,"alternative-id":["S0920121117303327"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2017.10.003","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of carbamazepine and oxcarbazepine on serum neuron-specific enolase in focal seizures: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2017.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}